Virginia Retirement Systems’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-31,000
| Closed | -$103K | – | 1012 |
|
|
2025
Q1 | $103K | Buy |
+31,000
| New | +$103K | ﹤0.01% | 999 |
|
|
2023
Q2 | – | Sell |
-11,200
| Closed | -$68.4K | – | 1035 |
|
|
2023
Q1 | $68.4K | Sell |
11,200
-6,900
| -38% | -$42.2K | ﹤0.01% | 1015 |
|
|
2022
Q4 | $116K | Sell |
18,100
-8,100
| -31% | -$51.8K | ﹤0.01% | 1091 |
|
|
2022
Q3 | $251K | Buy |
+26,200
| New | +$251K | ﹤0.01% | 996 |
|
|
2021
Q2 | – | Sell |
-7,900
| Closed | -$250K | – | 1081 |
|
|
2021
Q1 | $250K | Sell |
7,900
-1,700
| -18% | -$53.8K | ﹤0.01% | 1034 |
|
|
2020
Q4 | $445K | Buy |
9,600
+400
| +4% | +$18.5K | ﹤0.01% | 884 |
|
|
2020
Q3 | $303K | Sell |
9,200
-9,500
| -51% | -$313K | ﹤0.01% | 927 |
|
|
2020
Q2 | $513K | Sell |
18,700
-1,900
| -9% | -$52.1K | 0.01% | 786 |
|
|
2020
Q1 | $617K | Buy |
20,600
+300
| +1% | +$8.99K | 0.01% | 724 |
|
|
2019
Q4 | $562K | Buy |
+20,300
| New | +$562K | 0.01% | 898 |
|